US$295,710
US$188,507
20.0%
US$131,088
US$46,631
US$11,515
-US$726
US$4,767
/yr
Portfolio
S&P 500 (US)
A past performer with good growth potential
14 holdings
14
Symbol | Price Vs Fair Value | 7D Return | Total Return | Value & Cost | Weight & Shares | Avg. Price | 1Y chart | |
---|---|---|---|---|---|---|---|---|
TSLA Tesla | US$340.84 172.1% overvalued intrinsic discount | 6.5% +US$2,088 | 54.2% +US$11,979 | US$34,079 US$22,100 | 11.5% 100 | US$221.00 | ||
UNH UnitedHealth Group | US$261.57 69.8% undervalued intrinsic discount | 6.4% +US$316 | -35.4% -US$3,176 | US$5,231 US$8,960 | 1.8% 20 | US$448.00 | ||
BAC Bank of America | US$47.50 22.3% undervalued intrinsic discount | 4.6% +US$1,248 | 62.4% +US$11,920 | US$28,500 US$19,100 | 9.6% 600 | US$31.83 | ||
PLTR Palantir Technologies | US$186.97 147.1% overvalued intrinsic discount | 4.1% +US$743 | 999.8% +US$16,997 | US$18,697 US$1,700 | 6.3% 100 | US$17.00 | ||
META Meta Platforms | US$790.00 25.2% undervalued intrinsic discount | 2.3% +US$1,531 | 358.0% +US$56,778 | US$67,150 US$13,830 | 22.7% 85 | US$162.71 | ||
NVDA NVIDIA | US$183.16 58.8% overvalued intrinsic discount | 2.1% +US$147 | 881.8% +US$15,301 | US$7,324 US$1,443 | 2.5% 40 | US$36.06 | ||
BATS British American Tobacco | UK£42.88 32.3% undervalued intrinsic discount | 1.3% +US$520 | 43.7% +US$16,836 | US$40,506 US$26,990 | 13.7% 700 | UK£30.00 | ||
JNJ Johnson & Johnson | US$172.78 29.0% undervalued intrinsic discount | 1.3% +US$110 | 82.4% +US$4,203 | US$8,639 US$5,100 | 2.9% 50 | US$102.00 | ||
JPM JPMorgan Chase | US$292.85 15.8% undervalued intrinsic discount | 0.5% +US$75.00 | 46.0% +US$4,828 | US$14,643 US$10,500 | 5.0% 50 | US$210.00 | ||
XOM Exxon Mobil | US$106.13 56.7% undervalued intrinsic discount | -0.4% -US$77.90 | 91.4% +US$11,864 | US$21,757 US$12,897 | 7.4% 205 | US$62.91 | ||
AMZN Amazon.com | US$221.47 19.7% undervalued intrinsic discount | -0.4% -US$47.88 | 59.5% +US$4,937 | US$12,624 US$7,775 | 4.3% 57 | US$136.41 | ||
CRWD CrowdStrike Holdings | US$435.80 0.2% undervalued intrinsic discount | -3.5% -US$795 | 55.8% +US$10,095 | US$21,790 US$13,100 | 7.4% 50 | US$262.00 | ||
OKTA Okta | US$89.33 30.8% undervalued intrinsic discount | -8.6% -US$674 | -55.3% -US$8,854 | US$7,146 US$16,000 | 2.4% 80 | US$200.00 | ||
TLX Telix Pharmaceuticals | AU$16.68 72.0% undervalued intrinsic discount | -10.2% -US$868 | 82.1% +US$6,011 | US$7,624 US$5,128 | 2.6% 700 | AU$11.00 |
There are three easy ways to get started:
Simply Wall St goes far beyond price tracking. You'll be able to:
Most brokers and portfolio trackers only show prices and unrealised gains, with little context and lots of noisy news. Simply Wall St offers:
In short, Simply Wall St is more than a tracker — it's a complete investing platform for monitoring, analysing, and growing your portfolio.
Have feedback on the portfolio tool?